Literature DB >> 23254405

Esophageal self-expandable stent material and mesh grid density are the major determining factors of external beam radiation dose perturbation: results from a phantom model.

B K Abu Dayyeh1, J J Vandamme, R C Miller, T H Baron.   

Abstract

BACKGROUND: Self-expandable esophageal stents are increasingly used for palliation or as an adjunct to chemoradiation for esophageal neoplasia. The optimal esophageal stent design and material to minimize dose perturbation with external beam radiation are unknown. We sought to quantify the deviation from intended radiation dose as a function of stent material and mesh density design.
METHODS: A laboratory dosimetric film model was used to quantify perturbation of intended radiation dose among 16 different esophageal stents with varying material and stent mesh density design.
RESULTS: Radiation dose enhancement due to stent backscatter ranged from 0 % to 7.3 %, collectively representing a standard difference from the intended mean radiation dose of 1.9 (95 % confidence interval [CI] 1.5 - 2.2). This enhancement was negligible for polymer-based stents and approached 0 % for the biodegradable stents. In contrast, all metal alloy stents had significant radiation backscatter; this was largely determined by the density of mesh design and not by the type of alloy used.
CONCLUSIONS: Stent characteristics should be considered when selecting the optimal stent for treatment and palliation of malignant esophageal strictures, especially when adjuvant or neo-adjuvant radiotherapy is planned. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254405     DOI: 10.1055/s-0032-1325960

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  5 in total

Review 1.  Update on Enteral Stents.

Authors:  Emanuele Dabizzi; Paolo Giorgio Arcidiacono
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

2.  Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not?

Authors:  Yueh-Feng Lu; Chen-Shuan Chung; Chao-Yu Liu; Pei-Wei Shueng; Le-Jung Wu; Chen-Xiong Hsu; Deng-Yu Kuo; Pei-Yu Hou; Hsiu-Ling Chou; Ka-I Leong; Cheng-Hung How; San-Fang Chou; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Oncologist       Date:  2018-05-04

3.  Proton radiotherapy dose perturbations caused by esophageal stents of varying material composition are negligible in an experimental model.

Authors:  Sujai Jalaj; Sang Yeob Lee; Camille McGaw; Bijo K John; Zuofeng Li; Ziad T Awad; James S Scolapio; Juan C Munoz
Journal:  Endosc Int Open       Date:  2014-10-24

4.  Biodegradable esophageal stents in benign and malignant strictures - a single center experience.

Authors:  Dimitrios E Sigounas; Sandeep Siddhi; John N Plevris
Journal:  Endosc Int Open       Date:  2016-04-15

5.  Knowledge of endoscopic ultrasound-delivered fiducial composition and dimension necessary when planning proton beam radiotherapy.

Authors:  Ferga C Gleeson; Erik J Tryggestad; Nicholas B Remmes; Chris J Beltran; Jon J Kruse; Michael G Haddock; Christopher L Hallemeier; Andrew C Storm; Michael J Levy
Journal:  Endosc Int Open       Date:  2018-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.